Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Chemists Help Develop a Novel Drug to Fight Malaria

July 15, 2015 4:32 pm | by University of Washington | News | Comments

An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. Read more...


Pfizer to Close India Manufacturing Plant

July 15, 2015 2:36 pm | by Stephanie Guzowski, Editor | News | Comments

Pfizer will close its 50-year-old Thane manufacturing facility in Mumbai, by September 16, 2015, the company announced Wednesday. The facility has had no production activity since 2013, and the closure will not impact the supply of any of its medicines, according to Pfizer. Read more...


Taiwan's Pharmaceutical Market Value will Hit $8.4B by 2020

July 15, 2015 2:32 pm | by Joshua Owide, Director of Healthcare Industry Dynamics, GlobalData | Articles | Comments

This growth will happen despite diplomatic tensions.


Wider Use of Statins Has Positive Results, Say New Studies

July 15, 2015 1:16 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The Journal of the American Medical Association (JAMA) published two new studies on Tuesday that support controversial cholesterol guidelines. Read more...


Gene Therapy Makes Deaf Mice Hear

July 15, 2015 12:07 pm | by Cynthia Fox, Science Editor | Articles | Comments

For the first time, gene therapy partially restored hearing to young mice who were born stone-deaf due to a human deafness gene mutation. Read more...


BMS, MUSC: Research Collaboration on Fibrotic Diseases

July 15, 2015 12:04 pm | News | Comments

The Medical University of South Carolina and Bristol-Myers Squibb Company today announced that they have entered into a translational research collaboration focused on fibrotic diseases, including scleroderma, renal fibrosis and idiopathic pulmonary fibrosis. Read more...


Aratana Therapeutics Announces Positive Pivotal Results

July 15, 2015 12:00 pm | News | Comments

Aratana Therapeutics, Inc., a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today announced positive results from its pivotal field effectiveness study of AT-003, the company's innovative drug for treating post-surgical pain in dogs. Read more...


New Drug Reverses Anticoagulant Effects of Common Blood Thinner

July 15, 2015 11:50 am | by Northwestern University | News | Comments

An investigational drug has been shown to reverse the anticoagulant effects of dabigatran in patients who present with bleeding or need for emergent surgery. Dabigatran, sold under the brand name Pradaxa, is a blood-thinner used to prevent strokes in patients with the heart condition atrial fibrillation. Read more...


20 Health Care Innovators Selected for Aspen Institute Fellowship

July 15, 2015 11:44 am | News | Comments

The Aspen Institute today named 20 health care leaders selected to participate in the inaugural class of its Health Innovators Fellowship. This new two-year Fellowship will strengthen the leadership of innovators across the US health care ecosystem and challenge them to create new approaches that will improve the health and well-being of all Americans. Read more...


Ebola Vaccine Trial Begins in Senegal

July 15, 2015 9:02 am | by University of Oxford | News | Comments

The announcement comes as a conference in Oxford discusses the global response to Ebola and the implications for future drug and vaccine development. Read more...


Celgene will Buy Drug Developer Receptos for $7.32B

July 15, 2015 8:53 am | by The Associated Press | News | Comments

Celgene agreed to pay $232 per share for Receptos, and the companies valued the deal at $7.2 billion excluding Receptos' cash on hand. Read more...


GSK, Francis Crick Institute to Partner on Open R&D Projects

July 15, 2015 8:46 am | News | Comments

This is the first collaboration to be established between the Crick and a pharmaceutical company. Read more...


More than 200 Poles Sickened by 'Designer Drugs'

July 15, 2015 8:40 am | by The Associated Press | News | Comments

The drugs consist of powerful psychoactive substances sold as powders or ground leaves with warnings that they not be ingested, language that has so far allowed them to be sold in a legal gray zone. Read more...


Anti-hypertensive Therapeutics Market Value in Asia Pacific to Approach $20B by 2021

July 15, 2015 8:40 am | by Aswini Nath, Analyst, GBI Research | Articles | Comments

Japan is the largest anti-hypertensive therapy market among the four APAC countries, valued at $8.1 billion in 2014 and representing 52 percent of the region’s anti-hypertensive treatment space. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.